These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29409474)
1. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target? Vasaikar S; Tsipras G; Landázuri N; Costa H; Wilhelmi V; Scicluna P; Cui HL; Mohammad AA; Davoudi B; Shang M; Ananthaseshan S; Strååt K; Stragliotto G; Rahbar A; Wong KT; Tegner J; Yaiw KC; Söderberg-Naucler C BMC Cancer; 2018 Feb; 18(1):154. PubMed ID: 29409474 [TBL] [Abstract][Full Text] [Related]
2. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas. Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886 [TBL] [Abstract][Full Text] [Related]
3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
4. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
5. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients. Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis. Jangholi E; Tehran HA; Ghasemi A; Hoseinian M; Firoozi S; Ghodsi SM; Tamaddon M; Bereimipour A; Hadjighassem M Cancer Rep (Hoboken); 2024 Jul; 7(7):e2080. PubMed ID: 38967113 [TBL] [Abstract][Full Text] [Related]
7. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma. Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422 [TBL] [Abstract][Full Text] [Related]
8. Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Liu Y; Ye F; Yamada K; Tso JL; Zhang Y; Nguyen DH; Dong Q; Soto H; Choe J; Dembo A; Wheeler H; Eskin A; Schmid I; Yong WH; Mischel PS; Cloughesy TF; Kornblum HI; Nelson SF; Liau LM; Tso CL Mol Cancer Res; 2011 Dec; 9(12):1668-85. PubMed ID: 22013079 [TBL] [Abstract][Full Text] [Related]
9. COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value. Gao YF; Mao XY; Zhu T; Mao CX; Liu ZX; Wang ZB; Li L; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ Oncotarget; 2016 Oct; 7(43):70494-70503. PubMed ID: 27655637 [TBL] [Abstract][Full Text] [Related]
12. Identification of Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702 [No Abstract] [Full Text] [Related]
13. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma. Li K; Zhu Q; Du S; Zhao Q; Ba D; Zeng X; Peng Q; Cai J; Zhao Y; Jin H; Qi L Int Immunopharmacol; 2024 Sep; 138():112625. PubMed ID: 38996666 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelin B receptor in oligodendroglioma proliferation and survival: In vitro and in vivo evidence. Wan X; Zhang L; Jiang B Mol Med Rep; 2014 Jan; 9(1):229-34. PubMed ID: 24145738 [TBL] [Abstract][Full Text] [Related]
16. Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma. Tanaka T; Sho M; Takayama T; Wakatsuki K; Matsumoto S; Migita K; Ito M; Hamada K; Nakajima Y Br J Cancer; 2014 Feb; 110(4):1027-33. PubMed ID: 24357795 [TBL] [Abstract][Full Text] [Related]
17. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288 [TBL] [Abstract][Full Text] [Related]